Autopsy report · NCT01007851

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

“Lower than anticipated recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 2 months after it had already started.
• Ran for about 1 year 3 months before it stopped.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

V.K.V. American Hospital, Istanbul

Sponsor type

University, hospital or other

Conditions

Infertility

Interventions

triptorelin acetate; NaCl %0.9

Sites

1

Countries

Turkey (Türkiye)

Trials that died the same way

• Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
  “Recruitment lower than expected and negative results.” (89% match in meaning)
• Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy
  “low recruitment rate” (83% match in meaning)
• Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers
  “low recruitment” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.